#NAAS-SEC-Update-(08-SEP-2025)-ThinkSabio-Stocks Simplified)
SEC Filing Update: #NAAS : $2.81 Sector: Consumer Cyclical | YTD: 🔼+ 319.40 % The...
September 2025
#EVOK-SEC-Update-(08-SEP-2025)-ThinkSabio-Stocks Simplified)
SEC Filing Update: #EVOK : $6.05 Sector: Healthcare | YTD: 🔼+ 141.04 % The SEC...
#LB-SEC-Update-(08-SEP-2025)-ThinkSabio-Stocks Simplified)
SEC Filing Update: #LB : $51.22 Sector: Energy | YTD: 🔽 -29.56 % The SEC...
#CFBK-SEC-Update-(08-SEP-2025)-ThinkSabio-Stocks Simplified)
SEC Filing Update: #CFBK : $25.50 Sector: Financial Services | YTD: 🔼+ 16.60 % The...
Immutep Limited (IMMP) Stock price, Description, News & Info
#Thinksabio latest news Immutep Announces Data from EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft...
Keros Therapeutics, Inc. (KROS) Stock price, Description, News & Info
#Thinksabio latest news Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the...
BioAtla, Inc. (BCAB) Stock price, Description, News & Info
#Thinksabio latest news BioAtla Announces Regulatory Update on Clinical Development Plan for Ozuriftamab Vedotin in...
Enphase Energy, INC.(ENPH) Stock price, Description, News & Info
#Thinksabio latest news Enphase Energy Opens U.S. Pre-Orders for IQ9 Commercial Microinverters with GaN, Built...
Alignment Healthcare, Inc. (ALHC) Stock price, Description, News & Info
#Thinksabio latest news Alignment Healthcare Names Matt Eyles Executive Vice President of Government & Business...
TG Therapeutics, Inc. (TGTX) Stock price, Description, News & Info
#Thinksabio latest news TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced EnrollmentPhase 3 trial...